Mr. Jonathan Williams of Momentum PR reports

SIRONA BIOCHEM ANNOUNCES CHANGE OF AUDITOR

Sirona Biochem Corp. has changed its auditor from MNP LLP to DeVisser Gray LLP, effective Jan. 27, 2020. The board of directors of the company appointed the successor auditor as the company's auditor effective Jan. 27, 2020, until the next annual general meeting of the company. There were no reservations in the former auditor's audit reports for the relevant period, being the financial years ended Oct. 31, 2018, and Oct. 31, 2017, and any period subsequent to the most recently completed financial year for which an audit report was issued and preceding the resignation of the former auditor. In accordance with National Instrument 51-102 (Continuous Disclosure Obligations), the company has filed a change-of-auditor notice on SEDAR, together with letters from both the former auditor and successor auditor, with each lettering confirming agreement with the statements contained in the notice, as applicable. There were no reportable events as defined in NI 51-102 between the former auditor and the company.

About Sirona Biochem Corp.

Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona's subsidiary lab, TFChem, specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential. Sirona's compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and continuing royalty payments.

We seek Safe Harbor.